Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst W Radue

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurology|March 6, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSFJens Kuhle, Raija L P Lindberg, Axel Regeniter, et al.
The New England Journal of Medicine|September 15, 2006
Oral fingolimod (FTY720) for relapsing multiple sclerosisLudwig Kappos, Jack Antel, Giancarlo Comi, et al.
Biological Psychiatry|December 17, 2003
Differential sex-independent amygdala response to infant crying and laughing in parents versus nonparentsErich Seifritz, Fabrizio Esposito, John G Neuhoff, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosisCris S Constantinescu, Aliya Asher, Waldemar Fryze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disabilityStefan D Roosendaal, Kerstin Bendfeldt, Hugo Vrenken, et al.
Nature Reviews. Neurology|December 7, 2011
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trialsFrederik Barkhof, Jack H Simon, Franz Fazekas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosisCarsten Lukas, Dirk L Knol, Madeleine H Sombekke, et al.
Trials|May 11, 2019
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosisAntonio Uccelli, Alice Laroni, Lou Brundin, et al.
Radiology|June 6, 2013
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patientsCarsten Lukas, Madeleine H Sombekke, Barbara Bellenberg, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurology|March 6, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSFJens Kuhle, Raija L P Lindberg, Axel Regeniter, et al.
The New England Journal of Medicine|September 15, 2006
Oral fingolimod (FTY720) for relapsing multiple sclerosisLudwig Kappos, Jack Antel, Giancarlo Comi, et al.
Biological Psychiatry|December 17, 2003
Differential sex-independent amygdala response to infant crying and laughing in parents versus nonparentsErich Seifritz, Fabrizio Esposito, John G Neuhoff, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosisCris S Constantinescu, Aliya Asher, Waldemar Fryze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disabilityStefan D Roosendaal, Kerstin Bendfeldt, Hugo Vrenken, et al.
Nature Reviews. Neurology|December 7, 2011
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trialsFrederik Barkhof, Jack H Simon, Franz Fazekas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosisCarsten Lukas, Dirk L Knol, Madeleine H Sombekke, et al.
Trials|May 11, 2019
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosisAntonio Uccelli, Alice Laroni, Lou Brundin, et al.
Radiology|June 6, 2013
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patientsCarsten Lukas, Madeleine H Sombekke, Barbara Bellenberg, et al.
Pageof 2